TriSalus Life Sciences (TLSI) Net Equity Issued and Repurchased (2024 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Net Equity Issued and Repurchased of $42.6 million for Q1 2026, up 20301.42% quarter-over-quarter from -$211000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Net Equity Issued and Repurchased (2024 - 2026) Analysis & Trends
TriSalus Life Sciences' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $42.6 million for Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $42.6 million; the TTM figure through Mar 2026 stood at $64.6 million (up 440.21% YoY), while the FY2025 annual figure was $22.0 million, up 45.66% from the prior year.
- Net Equity Issued and Repurchased for Q1 2026 stood at $42.6 million, up from -$211000.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $42.6 million in Q1 2026, with the low at -$211000.0 in Q4 2025.
- The 3-year median for Net Equity Issued and Repurchased is $3.6 million (2024), against an average of $11.4 million.
- Peak annual rise in Net Equity Issued and Repurchased reached 516.63% in 2025, while the deepest fall reached 108.38% in 2025.
- TriSalus Life Sciences' Net Equity Issued and Repurchased stood at $2.5 million in 2024, then plunged by 108.38% to -$211000.0 in 2025, then soared by 20301.42% to $42.6 million in 2026.
- Business Quant data shows TLSI's Net Equity Issued and Repurchased at $42.6 million in Q1 2026, -$211000.0 in Q4 2025, and $22.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | TriSalus Life Sciences | 307.22 Mn | 260.94 Mn | 9.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.63 Mn |
| Mar 31, 2026 | 42.63 Mn |
| Dec 31, 2025 | -211,000.00 |
| Dec 31, 2025 | -211,000.00 |
| Jun 30, 2025 | 22.21 Mn |
| Jun 30, 2025 | 22.21 Mn |
| Dec 31, 2024 | 2.52 Mn |
| Dec 31, 2024 | 2.52 Mn |
| Sep 30, 2024 | 5.84 Mn |
| Sep 30, 2024 | 5.84 Mn |
| Jun 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | 3.60 Mn |
| Mar 31, 2024 | 3.14 Mn |
| Mar 31, 2024 | 3.14 Mn |